Man Group’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.73M Buy
177,876
+166,249
+1,430% +$6.15M 0.01% 1084
2025
Q4
$489K Sell
11,627
-639
-5% -$25.8K ﹤0.01% 1898
2025
Q3
$421K Sell
12,266
-114,305
-90% -$3.28M ﹤0.01% 1897
2025
Q2
$3.42M Buy
126,571
+42,404
+50% +$1.23M 0.01% 1224
2025
Q1
$2.5M Sell
84,167
-37,578
-31% -$1.43M 0.01% 1277
2024
Q4
$4.82M Sell
121,745
-294,029
-71% -$11.1M 0.01% 1027
2024
Q3
$14.2M Sell
415,774
-263,524
-39% -$7.41M 0.04% 580
2024
Q2
$14.7M Buy
679,298
+208,650
+44% +$4.39M 0.04% 531
2024
Q1
$10.4M Buy
470,648
+38,706
+9% +$944K 0.03% 685
2023
Q4
$11.9M Buy
+431,942
New +$10.4M 0.03% 571
2023
Q3
Sell
-60,622
Closed -$1.56M 877
2023
Q2
$1.54M Buy
+60,622
New +$1.47M ﹤0.01% 1270
2022
Q4
Sell
-35,334
Closed -$587K 2239
2022
Q3
$587K Buy
+35,334
New +$795K ﹤0.01% 1468
2022
Q2
Sell
-172,409
Closed -$3.48M 1383
2022
Q1
$4.75M Buy
+172,409
New +$4.93M 0.02% 914
2021
Q3
Sell
-11,900
Closed -$476K 2116
2021
Q2
$476K Buy
11,900
+3,000
+34% +$128K ﹤0.01% 1576
2021
Q1
$478K Sell
8,900
-1,474
-14% -$84.9K ﹤0.01% 1495
2020
Q4
$508K Buy
+10,374
New +$481K ﹤0.01% 1550

Other funds holding VCYT

Man Group's VCYT Position: Q1 2026 in Review

Man Group increased its Veracyte (VCYT) stake by 1,430% in Q1 2026, buying an estimated $6.15M and bringing the position to 177,876 shares worth $5.73M. The position accounts for 0.01% of the portfolio, ranked #1084.

Man Group first reported a position in VCYT in Q4 2020 and has held it in 16 quarters since. The position peaked at $14.7M in Q2 2024. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Man Group held 177,876 shares of Veracyte worth $5.73M as of Q1 2026.
  • Man Group bought 166,249 Veracyte shares in Q1 2026, an estimated $6.15M.
  • Veracyte made up 0.01% of Man Group's portfolio in Q1 2026, its #1084 holding.
  • Man Group first reported a position in Veracyte in Q4 2020 and has held it in 16 quarters since.
  • Man Group's Veracyte position peaked at $14.7M in Q2 2024.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.